# Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation

> **NCT00765882** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 633 (actual)

## Conditions studied

- Chronic Constipation

## Interventions

- **DRUG:** Linaclotide 290 micrograms
- **DRUG:** Linaclotide 145 micrograms
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00765882
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-07
- **Final completion:** 2009-08
- **Target enrollment:** 633 (ACTUAL)
- **Last updated:** 2013-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00765882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00765882, "Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00765882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*